The G53D mutation in Kir6.2 (KCNJ11) is associated with neonatal diabetes and motor dysfunction in adulthood that is improved with sulfonylurea therapy (Q24302959)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | The G53D mutation in Kir6.2 (KCNJ11) is associated with neonatal diabetes and motor dysfunction in adulthood that is improved with sulfonylurea therapy |
scientific article |
Statements
1 reference
The G53D mutation in Kir6.2 (KCNJ11) is associated with neonatal diabetes and motor dysfunction in adulthood that is improved with sulfonylurea therapy (English)
1 reference
Joseph C Koster
1 reference
Francesco Cadario
1 reference
Cinzia Peruzzi
1 reference
Carlo Colombo
1 reference
Colin G Nichols
1 reference
11 December 2007
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference